Showing 20 of 27 recruiting trials for “burkitt-lymphoma”
Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL
RecruitingNCT07356882 ↗
European Project for ctDNA Detection as a Biomarker for Non-invasive Therapy Monitoring in Paediatric Classical Hodgkin Lymphoma
👨⚕️ Mathieu SIMONIN, MD, Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Nov 2025View details ↗
A Study to Investigate the Pharmacokinetics of Tirabrutinib in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Healthy Participants
A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma（SELINA）
A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
👨⚕️ François LEMONNIER, Pr, Hôpital Henri Mondor - Lymphoid Malignancies Unit📍 20 sites📅 Started Aug 2025View details ↗
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell Malignancies
Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study
Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment
PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
👨⚕️ Shuhua Yi, Doctor, Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Aug 2024View details ↗
RecruitingNCT06796517 ↗
Immunotherapy in Lymphoma
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
👨⚕️ Daniel R Richardson, MD, MA, MSc, UNC Lineberger Comprehensive Cancer Center📍 1 site📅 Started Jun 2024View details ↗
Effects of Exercise Training in Survivors of Lymphoma
👨⚕️ Tormod S. Nilsen, PhD, Norwegian School of Sport Sciences📍 2 sites📅 Started Mar 2024View details ↗
Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine
Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin Lymphoma
👨⚕️ Andreas Engert, Prof., 1st Department of Medicine, Cologne Universit Hospital📍 1 site📅 Started Mar 2024View details ↗
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
👨⚕️ Kelly McConnell, PhD, Memorial Sloan Kettering Cancer Center📍 2 sites📅 Started Jul 2023View details ↗
A Study of Zimberelimab(GLS-010) Combined With AVD for Newly Diagnosed Early-stage Hodgkin's Lymphoma
RecruitingNCT06241729 ↗
Prospective Observational Study of Diffuse Large-cell B Lymphoma
RecruitingNCT06073938 ↗
Compassionate Use Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT Rearrangement
RecruitingNCT05506410 ↗
A Clinical Study of Hanlikang and BTK Inhibitors in the Treatment of Newly Diagnosed Mantle Cell Lymphoma
👨⚕️ Zhang Mingzhi Zhang, The First Affiliated Hospital of Zhengzhou University📍 1 site📅 Started Aug 2022View details ↗
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →